Byler Disease
📧 Sign up to get email alerts when something new happens for Byler Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Expanded Access Protocol for an Intermediate Size Population - RAVICTI for Byler Disease
The expanded access protocol for RAVICTI to treat Byler disease is no longer available.
-
CLINICAL_TRIALS withdrawal · 2013-09-24Clinical Trial Update: Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease
Clinical trial update indicates the study comparing Buphenyl to Ravicti for Byler disease is no longer available, effectively ending the tra…